Ireland
--:--IST
Latest
Clinical Trials in Portugal / NCT01974362
Recruiting Observational

Monolithic Zirconia Full-Mouth Implant Supported Rehabilitation Behavior

NCT01974362 · tracked via the Priya Life Science Portugal tracker
Sponsor
Implantology Institute
Phase
Observational
Started
2014-01
Last updated
2026-05-04

Condition(s) studied

Endosseous Dental Implant FailureAccident Caused by Broken Ceramic

Investigational drug(s) / intervention(s)

Dental ImplantMonolithic Zirconia (MZ)Zirconia-Feldspathic (PVZ)Monolithic Zirconia (FCMZ)

Dental Implant: Place dental implants in both jaws (maxilla and mandible) according to manufacturer specifications

Monolithic Zirconia (MZ): rehabilitation with monolithic zirconia implant-prosthesis with bucal feldspathic veneer

Zirconia-Feldspathic (PVZ): restore dental implants with a zirconia suprastructure and feldspathic veneers

Monolithic Zirconia (FCMZ): Full contour full arch zirconia rehabilitation

Study summary

In patients that did a full mouth implant supported rehabilitation does Cad/Cam Monolithic Zirconia compared to Cad/Cam Zirconia Suprastructure (zirconium oxide (Yttrium - partially stabilized with tetragonal polycrystalline structure) veneered with feldspathic ceramic, has less post-insertion complications after at least 1-Year follow-up ?

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Maxilla and/or Mandible Implant full-mouth restoration * Monolithic ceramic or zirconia-feldspathic restoration * be at least 18 years of age; * present no systemic or local absolute contraindications for endosseous implant placement; * at least 1 Year Follow-up Exclusion Criteria: * the presence of any systemic disease or condition that could compromise postoperative healing or osseointegration. * Not full mouth rehabilitation

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Artur Simões Lisbon Lisbon District Recruiting

More Implantology Institute trials in Portugal

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT01974362 on ClinicalTrials.gov ↗ ← All trials in Portugal